Correlation Between Apogee Therapeutics, and ENELIM

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and ENELIM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and ENELIM into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and ENELIM 225 12 JUL 31, you can compare the effects of market volatilities on Apogee Therapeutics, and ENELIM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of ENELIM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and ENELIM.

Diversification Opportunities for Apogee Therapeutics, and ENELIM

0.23

Correlation Coefficient

Apogee Therapeutics,  ENELIM

Modest diversification

The 3 months correlation between Apogee and ENELIM is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and ENELIM 225 12 JUL 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENELIM 225 12 and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with ENELIM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENELIM 225 12 has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and ENELIM go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and ENELIM

Given the investment horizon of 90 days Apogee Therapeutics, is expected to generate 2.41 times less return on investment than ENELIM. In addition to that, Apogee Therapeutics, is 1.4 times more volatile than ENELIM 225 12 JUL 31. It trades about 0.02 of its total potential returns per unit of risk. ENELIM 225 12 JUL 31 is currently generating about 0.05 per unit of volatility. If you would invest  7,509  in ENELIM 225 12 JUL 31 on September 12, 2024 and sell it today you would earn a total of  357.00  from holding ENELIM 225 12 JUL 31 or generate 4.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	67.19%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  ENELIM 225 12 JUL 31

Apogee Therapeutics,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Apogee Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

ENELIM 225 12

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ENELIM 225 12 JUL 31 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, ENELIM may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Apogee Therapeutics, and ENELIM

The main advantage of trading using opposite Apogee Therapeutics, and ENELIM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, ENELIM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENELIM will offset losses from the drop in ENELIM's long position.

The idea behind Apogee Therapeutics, Common and ENELIM 225 12 JUL 31 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.